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Abstract
Fazzio, L.E.; Giuliodori, M.J.; Galván, W.R.; Streitenberger, N.; Landoni, M.F.: A 
metaphylactic treatment with double dose oxytetracycline reduces the risk of bovine 
respiratory disease in feedlot calves. Rev. vet. 26: 2, 89-92, 2015. The objective of this 
study was to evaluate the effect of a metaphylactic treatment with oxytetracycline (OTC) 
in the labeled and double doses on the risk for bovine respiratory disease (BRD) in feedlot 
calves. This study was conducted in a commercial feedlot where 2,754 calves belonging to 
high risk groups were enrolled. A randomized complete block design was used, with ani-
mals as experimental units and pens (n=10) as blocks. Three experimental groups were as-
sessed: 1- untreated control (CTL), 2- OTC 20 mg/kg SC (OTC20) and 3- OTC 40 mg/kg SC 
(OTC40). The risk for BRD was evaluated with a mixed logistic regression. Untreated CTL 
had 2.85 and 7.14 more chances of getting BRD than OTC20 and OTC40 groups, respectively 
(p<0.001). In conclusion, metaphylactic treatment with OTC is useful to reduce the risk for 
BRD in feedlot cattle, being protective effect higher at double dose than at labeled one.
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Resumen
Fazzio, L.E.; Giuliodori, M.J.; Galván, W.R.; Streitenberger, N.; Landoni, M.F.: Un 
tratamiento metafiláctico con doble dosis de oxitetraciclina reduce el riesgo de enferme-
dad respiratoria bovina en terneros de engorde a corral. Rev. vet. 26: 2, 89-92, 2015. El 
objetivo del presente estudio fue evaluar el efecto del tratamiento metafiláctico con oxite-
traciclina (OTC), a simple y doble dosis, en bovinos con alto riesgo de padecer enfermedad 
respiratoria bovina (ERB). El estudio se realizó en un establecimiento de engorde a corral 
donde se utilizaron 2.754 terneros que fueron considerados de alto riesgo de padecer ERB. 
Se utilizó un diseño en bloque completamente al azar donde se consideró al animal como la 
unidad experimental y el corral (n=10) como bloque. Se formaron tres grupos experimen-
tales: 1- control (CTL) el cual permaneció sin tratamiento, 2- recibió OTC 20 mg/kg SC 
(OTC20) y 3- recibió OTC 40 mg/kg SC (OTC40). El riesgo de ERB fue evaluado a través de 
una regresión logística. Los animales del grupo CTL tuvieron 2,85 y 7,14 veces más chances 
de enfermarse de ERB que los animales de los grupos OTC20 y OTC40 respectivamente 
(p<0,001). En conclusión, el tratamiento metafiláctico con OTC es útil para reducir el riesgo 
de padecer ERB en engorde a corral, siendo su efecto mayor cuando se aplica a la dosis de 
40 mg/kg. 
Palabras clave: ternero, enfermedad respiratoria bovina, oxitetraciclina, tratamiento meta-
filáctico. 
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INTRODUCTION
Bovine respiratory disease (BRD) is the single 
most important health problem in feedlot cattle 12, 19 . 
It is well known that BRD causes lower daily weight 
gains, poor feed efficiency and carcass quality, and 
death 10, 19, 23 . It has been reported that BRD is the re-
sult of a complex interaction among infectious agents, 
stress, management and individual susceptibility 16, 21 . 
Among infectious agents involved are viruses and bac-
teria such as Pasteurella multocida and Mannheimia 
haemolytica 6, 18 . Many authors have reported that 
metaphylactic treatment with drugs such as ceftiofur, 
florfenicol, tilmicosin, tulathromycinand, and oxytet-
racycline (OTC) is a useful tool to reduce the number of 
BRD-affected animals within a population 4, 7, 20 . In this 
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sense, OTC is a broad-spectrum antibiotic with a good 
tissue distribution that is available in long-acting prepa-
rations and therefore, it would be suitable for metaphy-
lactic use 2, 5, 20 . The use of long acting OTC prepara-
tions subcutaneous (SC) in calves has advantages over 
IM administration route for eliminating damage to ed-
ible meat and it has been approved by FDA 8, 24 . 
In addition, OTC treatment effect could be en-
hanced if the drug is administered at a higher dose, 
40 mg/kg 22 . However, no study has compared the 
metaphylactic effect of a single administration of OTC 
at labeled (20 mg/kg) vs double dose (40 mg/kg) in 
feedlot calves. Therefore, the objective of this study 
was to evaluate the effect of a metaphylactic treatment 
with OTC in the labeled and double doses on the risk 
for BRD in feedlot calves. The working hypothesis was 
that a metaphylactic treatment with OTC reduces the 
risk for BRD in feedlot, and that the efficacy of the 
double dose is higher. 
MATERIAL AND METHODS
This study was conducted in a commercial feedlot 
located in Marcos Paz, Buenos Aires Province, Argen-
tina (34°08’S, 58°08W). Male and female calves (n= 
2,754) from Hereford, A. Angus, Bradford and Brangus 
breeds with an entrance weight of 120 ± 22 kg (mean ± 
SD) were enrolled. Animals were kept for 72 h in admis-
sion pens with free access to high quality hay and clean 
water. Then, calves were identified (ear tags) and re-
ceived a SC single dose of a polyvalent clostridium vac-
cine (Policlostrigen, Biogénesis-Bagó, Argentina) and a 
SC single dose of ivermectin (Ivergen Biogénesis-Bagó, 
Argentina). Diet was based on corn grain, sunflower 
meal, wheat bran and vitamin-mineral supplement. Fi-
ber content of the initial ration was 25% and then de-
creased progressively up to 5% in the finishing ration. 
The inclusion criteria considered as “high risk 
group for BRD” to those groups where at least 10% 
of the calves showed poor body condition score, eye 
and/or nasal discharge, and cough at the start of the 
study. Duration of the trip from auction market to feed-
lot, weather conditions and lack of health records were 
also taken into account. A randomized complete block 
design was used, with animals (n= 2,754) as experi-
mental units and pens (n= 10) as blocks. In each 
pen three experimental groups were randomly 
formed: 1- untreated control (CTL, n= 893), 2- 
Oxytetracyclin 20 mg/kg SC (OTC20, Maxibi-
otic 20% Biogénesis-Bagó, Argentina, n= 900), 
and 3- Oxytetracyclin 40 mg/kg SC (OTC40, 
Maxibiotic 20% Biogénesis-Bagó, Argentina, n= 
961). All the studied animals were kept in their 
assigned pens, so that no animal was allowed 
either to enter or to change the pen once the ex-
periment was in progress. 
Animals in pens were observed twice daily 
by trained personnel in the diagnosis of BRD. 
Animals showing signs of BRD (depression, 
eye or nose discharge, anorexia, dyspnea, cough, rec-
tal temperature ≥39.5°C, orthopneic posture) received 
a rescue therapeutic treatment with tilmicosin SC 10 
mg/kg (Micotil, Elanco Animal Health) plus meloxi-
cam 0.5 mg/kg (Metacam 20% Boehringer Ingelheim). 
Dead animals were necropsied and collected tissues 
sampled for bacteriological analysis. All the cases of 
BRD, treatments, and related deaths were recorded. In 
one of the pens, 90 animals (30 per group) were ran-
domly selected and their liveweights measured on days 
0, 21, and 50.
The risks for BRD and for death as a consequence 
of BRD were evaluated by using a mixed logistic re-
gression with a binomial distribution and a logit link 
function. The logistic model included the fixed effect of 
treatment (CTL vs OTC20 vs OTC40) and the random 
effect of pens 14, 15 . The interval of time to BRD oc-
currence was evaluated with a cox proportional hazard 
regression analysis with the fixed effect of treatment 
(CTL vs OTC20 vs OTC40) and also with a Kaplan-
Meier survival analysis 1 . Average daily weight gains 
(ADG) were evaluated by using a linear mixed model 
that included the fixed effect of treatment (CTL vs 
OTC20 vs OTC40) and the random effect of the animal 
16 . Statistical significance was set at p<0.05 and a trend 
for significance at p<0.10 and >0.05.
RESULTS
The incidence of BRD decreased from 7.95% in the 
CTL group up to 3.33% in the OTC20 and up to 1.24% 
in the OTC40 group (Table 1). The metaphylactic treat-
ment with OTC reduced the risk for BRD (Table 1). Un-
treated animals (CTL) had 2.85 (1/0.35) more chances 
of getting BRD than the OTC20, and 7.14 (1/0.14) more 
chances of having BRD than the OTC40 animals (Ta-
ble 1). 
In addition, metaphylactic treatment with OTC 
reduced the hazard ratio for BRD (HR=0.39, 95% 
CI=0.30-0.51, p<0.001, Figure 1), and extended 7 days 
the interval of time from arrival to the diagnosis of BRD 
in all the calves becoming sick (Figure 2). That is, CTL 
group had a median (95% CI) of 9 (8-13) days to BRD, 
while OTC20 had 16 days (14-24) and OTC40 had 16.5 
(15-22) days to disease (log rank test: p=0.005, df=2). 
Table 1. Effect of metaphylactic treatment with oxytetra-
cycline on the risk for bovine respiratory disease in feedlot 
calves (n=2,754)
treatment
incidence risk of bovine respiratory disease
% n OR IC 95% p
CTL 7.95 71/893 referent - <0.001
OTC20 3.33 30/900 0.352 0.181-0.683
OTC40 1.24 12/961 0.141 0.077-0.259
OR = odds ratio; IC 95% = 95% confidence interval; CTL = control 
group left untreated; OTC20 = group treated with a single dose of 
oxytetracycline (20 mg/kg); OTC40 = group treated with a single 
dose of oxytetracycline (40 mg/kg).
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Mortality rates were 0.22, 0.11 and 0.10% for 
CTL, OTC20 and OTC40, respectively. Four dead 
calves were observed (2 in CTL, 1 in OTC20, and 1 in 
OTC40). It was not possible to estimate the effects of 
OTC on the risk for death because there were very few 
dead animals. Bronchopneumonia was diagnosed in 3 
animals (2 in CTL, and 1 in OTC20), while pleuroneu-
monia was diagnosed on the dead calf belonging to the 
OTC40 group. 
Consolidated and dark red lesions showed cranio-
ventral distribution in both lungs. Bacteriological stud-
ies showed the presence of Pasteurella multocida (n=1) 
and Mannheimia haemolytica (n=1) in CTL, Pasteu-
rella multocida and Mannheimia haemolytica (n=1) in 
OTC20, and Mannheimia haemolytica (n=1) in OTC40. 
Susceptibility tests performed on isolated strains 
showed high sensitivity to OTC, tilmicosin, florfenicol, 
phosphomycin, and streptomycin.
Metaphylactic treatment with OTC showed an ef-
fect on average daily gain (ADG) during the entire study 
time, although it did not reach statistical significance 
(p=0.062, Table 2); CTL animals gained 76.4 g/d less 
than OTC20 (p=0.059), and 89.0 g/d less than OTC40 
animals (p=0.030). The ADG during the first 21 days 
of study was affected by OTC (p<0.001, Table 2); CTL 
gained 269.5 g/d less than OTC20 (p=0.001) and 357.4 
g/d less than OTC40 (p=0.001). Finally, ADG during 
the last 29 days of study was not affected by OTC ad-
ministration (p=0.180, Table 2).
DISCUSSION
The hypothesis of this study was that a metaphy-
lactic treatment with OTC reduces the risk for BRD 
in feedlot cattle. In support of this hypothesis it was 
found that the incidence of BRD and the risk of BRD 
decreased after OTC treatment at both, labeled and 
double therapeutic doses. This result is expected on the 
basis that OTC is classified as a type III antimicrobial 
with time-dependent killing and moderate persistent 
effects. Therefore, ideal dosing regimen for these anti-
biotics maximizes the amount of drug received, being 
the area under the serum concentration curve/ mini-
mum inhibitory concentration ratio the parameter that 
best correlates with efficacy 13, 17 . 
Another interesting finding was that the hazard ra-
tio for BRD was also reduced by OTC treatment and 
therefore, the median interval of time from arrival to 
BRD diagnosis was extended (approximately 7 days) 
by OTC treatment. This could be explained for the long 
lasting effect of OTC; treated animals are under the 
Table 2. Mixed model effects of the metaphylactic 
treatment with oxytetracycline on average daily 
weight gain in feedlot calves (n=90)
ADG
LSMd
SEe p
CTLa OTC20b OTC40c
ADGtf 939.4X 1015.8X,Y 1028.4Y 28.7 0.062
ADG1g 547.9X 817.4Y 905.3Y 60.1 <0.001
ADG2h 1217.6X 1158.6X 1116.5X 38.4 0.180
aCTL = control group (n=30) left untreated; bOTC20 = 
group treated (n=30) with a single dose of Oxytetracycline 
(20 mg/kg); cOTC40 = group treated (n=30) with a single 
dose of Oxytetracycline (40 mg/kg); dLSM = least squared 
means; eSE = standard errors (highest value reported); 
fADGt = average daily gain (in grams) during all the study 
period (50 days); gADG1 = average daily gain (in grams) 
from 0 through 21 days of study (period 1); hADG2 = ave-
rage daily gain (in grams) from 21 through 50 days of study 
(period 2); X,YDifferent capital letters within rows means 
p<0.05.
Figure 2. Effect of metaphylactic treatment with Oxy-
tetracycline on the interval of time from arrival to the 
diagnosis of bovine respiratory disease in feedlot cal-
ves that developed the disease during the study (n=71 
for Control [CTL], n=30 for Oxytetracycline 20 mg/
kg [OTC20], and n=12 for Oxytetracycline 40 mg/kg 
[OTC40]).
Figure 1. Effect of metaphylactic treatment with 
oxytetracycline on the interval of time from arrival 
to the diagnosis of bovine respiratory disease in fee-
dlot calves (n=2,754, Control [CTL], Oxytetracycline 
20 mg/kg [OTC20], and Oxytetracycline 40 mg/kg 
[OTC40]).
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protective effect of OTC shortly after arriving when 
the risk for BRD is the highest 21 . In fact, it has been re-
ported that administration of a single dose of 20 and 40 
mg/kg of OTC to calves produced lung concentrations 
of 2 µg/ml for 48 and 72 h, respectively 22 .
Regarding ADG, CTL animals gained less weight 
during the study than the two OTC groups. This finding 
is expected since a higher proportion of animals were 
affected by BRD in the CTL group than in the OTC 
groups. One reason could be that sick calves have a low-
er dry matter intake what would decrease ADG 9, 23 . An-
other reason could be that sick animals shift energetic 
fuels from productive tissues to defense tissues in an 
attempt to save “fuel” to match the higher demands of 
the immune system fighting against lung infection 3, 11 . 
These facts could explain why BRD-affected animals 
gain less weight than healthy pen-mates.
In conclusion, metaphylactic treatment with OTC 
reduces the risk for BRD in feedlot cattle, and that 
the protective effect is higher at double dose than at 
labeled one. In addition, metaphylactic treatment with 
OTC improves weight gain during the first weeks after 
feedlot entrance.
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